1[1]Verdecchia P,Schillaci G,Borgioni C,et al. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure[J]. Blood Press Monit,1996,1(3):217-222.
2[2]Pannarale G, Collauto F, Serafini GL,et al. Influence of antihypertensive therapy on the "white coat effect"[J].Minerva Cardioangiol,1994,42(4):169-172.
3[3]Marquez Contreras E, Casado Martinez JJ, Gil Rodriguez R,et al. White coat hypertension: clinical performance after its primary care diagnosis[J]. Aten Primaria,1999,24(2):92-96.
4[4]Pose-Reino A, Gonzalez-Juanatey JR, Pastor C,et al.Clinical implications of white coat hypertension[J]. Blood Press,1996,5(5):264-273.
5[5]Pierdomenico SD, Mezzetti A, Lapenna D,et al. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care[J]. Eur Heart J,1995,16(5):692-697.
6[6]Nakao M, Nomura S, Shimosawa T,et al. Blood pressure biofeedback treatment of white-coat hypertension[J]. J Psychosom Res,2000,48(2):161-169.
7[7]Nalbantgil I, Onder R, Nalbantgil S,et al. The prevalence of silent myocardial ischaemia in patients with white-coat hypertension[J]. J Hum Hypertens,1998,12(5):337-341.
9[9]Sandvik E, Steine S. White coat hypertension in a general practice. Prevalence, cardiovascular risk factors and clinical implications[J]. Scand J Prim Health Care,1998,16(4):222-226.
10[10]Thomas G, Pickering D. White Coat Hypertension:Time for Action[J]. Circulation,1998,98:1834-1836.
2White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy [J]. Am J cardiol, 1989, 63(1):94-98.
3Neumann SA, Jenings JR, Muldoon MF, et al. Whitecoat hypertension and autonomic nervous system dysregulation [J]. Am J hypertens ,2005,18(5 pt 1):584-588.
4Bjorklund K, Lind L, Vessby B, et al. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men [J].Circulation,2002,106(1):63-68.
5Kario K, Shimaka K, Schwartz JE, et al. Silent and clinically overt stroke in older Japanese subjects with whitecoat and sustained hypertension[J]. J Cardiol,2002,39(1): 52-54.
6Verdecchia P, Angeli F, Gattobigio R, et al. The clinical significance of white-coat and masked hypertension [J]. Blood Press Monit,2007,12(6):387-389.
7Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: prospective cohort study[J]. Eur Heart J, 2000, 21(20):1714-1718.
